Skip to main content
British Medical Journal logoLink to British Medical Journal
. 1976 May 29;1(6021):1300–1301.

Editorial: Ectopic secretion by tumours.

PMCID: PMC1640293  PMID: 178403

Full text

PDF
1300

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Amatruda T. T., Jr, Upton G. V. Paraneoplastic syndromes. Hyperadrenocorticism and ACTH-releasing factor. Ann N Y Acad Sci. 1974;230:168–180. doi: 10.1111/j.1749-6632.1974.tb14445.x. [DOI] [PubMed] [Google Scholar]
  2. BOWER B. F., MASON D. M., FORSHAM P. H. BRONCHOGENIC CARCINOMA WITH INAPPROPRIATE ANTIDIURETIC ACTIVITY IN PLASMA AND TUMOR. N Engl J Med. 1964 Oct 29;271:934–938. doi: 10.1056/NEJM196410292711804. [DOI] [PubMed] [Google Scholar]
  3. Bagshawe K. D. Radioimmunoassay and saturation analysis. Tumor-associated antigens. Br Med Bull. 1974 Jan;30(1):68–73. doi: 10.1093/oxfordjournals.bmb.a071170. [DOI] [PubMed] [Google Scholar]
  4. Barraclough M. A., Jones J. J., Lee J. Production of vasopressin by anaplastic oat cell carcinoma of the bronchus. Clin Sci. 1966 Aug;31(1):135–144. [PubMed] [Google Scholar]
  5. Beck C., Larkins R. G., Martin T. J., Burger H. G. Stimulation of growth hormone release from superfused rat pituitary by extracts of hypothalamus and of human lung tumours. J Endocrinol. 1973 Nov;59(2):325–333. doi: 10.1677/joe.0.0590325. [DOI] [PubMed] [Google Scholar]
  6. Benson R. C., Jr, Riggs B. L., Pickard B. M., Arnaud C. D. Immunoreactive forms of circulating parathyroid hormone in primary and ectopic hyperparathyroidism. J Clin Invest. 1974 Jul;54(1):175–181. doi: 10.1172/JCI107739. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Gewirtz G., Yalow R. S. Ectopic ACTH production in carcinoma of the lung. J Clin Invest. 1974 Apr;53(4):1022–1032. doi: 10.1172/JCI107639. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Hillyard C. J., Coombes R. C., Greenberg P. B., Galante L. S., MacIntyre I. Calcitonin in breast and lung cancer. Clin Endocrinol (Oxf) 1976 Jan;5(1):1–8. [PubMed] [Google Scholar]
  9. LEE J., JONES J. J., BARRACLOUGH M. A. INAPPROPRIATE SECRETION OF VASOPRESSIN. Lancet. 1964 Oct 10;2(7363):792–793. doi: 10.1016/s0140-6736(64)90566-5. [DOI] [PubMed] [Google Scholar]
  10. Mundy G. R., Raisz L. G., Cooper R. A., Schechter G. P., Salmon S. E. Evidence for the secretion of an osteoclast stimulating factor in myeloma. N Engl J Med. 1974 Nov 14;291(20):1041–1046. doi: 10.1056/NEJM197411142912001. [DOI] [PubMed] [Google Scholar]
  11. Rees L. H. The biosynthesis of hormones by non-endocrine tumours--a review. J Endocrinol. 1975 Oct;67(1):143–175. doi: 10.1677/joe.0.0670143. [DOI] [PubMed] [Google Scholar]
  12. Seyberth H. W., Segre G. V., Morgan J. L., Sweetman B. J., Potts J. T., Jr, Oates J. A. Prostaglandins as mediators of hypercalcemia associated with certain types of cancer. N Engl J Med. 1975 Dec 18;293(25):1278–1283. doi: 10.1056/NEJM197512182932502. [DOI] [PubMed] [Google Scholar]
  13. Shapiro M., Nicholson W. E., Orth D. N., Mitchell W. M., Liddle G. W. Differences between ectopic MSH and pituitary MSH. J Clin Endocrinol Metab. 1971 Sep;33(3):377–381. doi: 10.1210/jcem-33-3-377. [DOI] [PubMed] [Google Scholar]
  14. Tashjian A. H., Jr, Voelkel E. F., Levine L., Goldhaber P. Evidence that the bone resorption-stimulating factor produced by mouse fibrosarcoma cells is prostaglandin E 2 . A new model for the hypercalcemia of cancer. J Exp Med. 1972 Dec 1;136(6):1329–1343. doi: 10.1084/jem.136.6.1329. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Weintraub B. D., Krauth G., Rosen S. W., Babson A. S. Differences between purified ectopic and normal alpha subnits of human glycoprotein hormones. J Clin Invest. 1975 Oct;56(4):1043–1052. doi: 10.1172/JCI108151. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES